Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Comment by KevinOlearyon Sep 11, 2024 1:00pm
24 Views
Post# 36218794

RE:Technical analysis

RE:Technical analysisTA is a useless summary of yesterday's trading statistics which are useless counts of how many shares traded and how many times sellers and buyers made a trade etc. I have never used TA.
People buy and sell for the wrong reasons, so why should I waste time wondering what they are/were thinking, when I can figure where kne is going fto end up at, from the info provided by the ceo?  The useful answers come from the NRs and webinars, not from someone who doesn't work at the company who makes a trade.
More Revyve products will be in the market soon, and they are adding distributors, so we should have positive cash flow. That's all the info we need to know for the short term, and the bigger dispersin products will eventually come into the market and make us rich in the long term. You won't find that answer in a TA chart.
<< Previous
Bullboard Posts
Next >>